We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+6.73%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$388M
AUM Growth
-$19.9M
Cap. Flow
-$43M
Cap. Flow %
-11.1%
Top 10 Hldgs %
46.62%
Holding
67
New
4
Increased
7
Reduced
44
Closed
3

Top Buys

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$4.37M
2
CME icon
CME Group
CME
+$3.99M
3
ALSN icon
Allison Transmission
ALSN
+$3.28M
4
ROST icon
Ross Stores
ROST
+$2.64M
5
LHX icon
L3Harris
LHX
+$2.31M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.11M
2
JNJ icon
Johnson & Johnson
JNJ
+$6.69M
3
CSCO icon
Cisco
CSCO
+$6.53M
4
UNH icon
UnitedHealth
UNH
+$4.7M
5
MDT icon
Medtronic
MDT
+$3.14M

Sector Composition

Rank Sector Weight
1 Healthcare 25.96%
2 Technology 22.25%
3 Industrials 16.64%
4 Consumer Staples 14.64%
5 Financials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRT icon
26
Copart
CPRT
$27.1B
$5.41M 1.4%
205,692
-5,504
-3% -$133K
GWW icon
27
W.W. Grainger
GWW
$64.9B
$5.28M 1.36%
14,792
-27
-0.2% -$9.3K
META icon
28
Meta Platforms (Facebook)
META
$1.51T
$5.26M 1.36%
20,087
-7,580
-27% -$1.95M
NVS icon
29
Novartis
NVS
$292B
$5.24M 1.35%
60,289
+1,534
+3% +$133K
TRU icon
30
TransUnion
TRU
$15.2B
$4.7M 1.21%
55,863
-1,352
-2% -$117K
KO icon
31
Coca-Cola
KO
$374B
$4.63M 1.19%
93,720
SBUX icon
32
Starbucks
SBUX
$119B
$4M 1.03%
46,494
-33,670
-42% -$2.69M
CME icon
33
CME Group
CME
$95.5B
$3.97M 1.02%
+23,717
New +$3.99M
DOX icon
34
Amdocs
DOX
$5.93B
$3.67M 0.95%
64,000
-23,712
-27% -$1.42M
BRK.B icon
35
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.48M 0.9%
16,323
BDX icon
36
Becton Dickinson
BDX
$46.7B
$3.24M 0.84%
14,281
+7,823
+121% +$1.92M
ALSN icon
37
Allison Transmission
ALSN
$9.66B
$3.18M 0.82%
+90,511
New +$3.28M
BTI icon
38
British American Tobacco
BTI
$129B
$3.1M 0.8%
85,788
-3,368
-4% -$118K
SONY icon
39
Sony
SONY
$133B
$3.06M 0.79%
199,125
-8,755
-4% -$136K
GNTX icon
40
Gentex
GNTX
$4.97B
$2.83M 0.73%
110,090
-39,474
-26% -$1.05M
WMT icon
41
Walmart Inc
WMT
$881B
$2.79M 0.72%
59,850
ROST icon
42
Ross Stores
ROST
$81B
$2.75M 0.71%
+29,443
New +$2.64M
SWK icon
43
Stanley Black & Decker
SWK
$14.7B
$2.43M 0.63%
14,972
-56
-0.4% -$8.72K
SNY icon
44
Sanofi
SNY
$103B
$2.42M 0.63%
48,313
-3,965
-8% -$204K
CHKP icon
45
Check Point Software Technologies
CHKP
$12.6B
$2.23M 0.58%
18,552
-1,643
-8% -$200K
UL icon
46
Unilever
UL
$138B
$2.2M 0.57%
31,697
-3,401
-10% -$227K
SAP icon
47
SAP
SAP
$220B
$2.13M 0.55%
13,694
-1,164
-8% -$185K
DD icon
48
DuPont de Nemours
DD
$18.9B
$1.98M 0.51%
28,439
-19,759
-41% -$1.38M
MMM icon
49
3M
MMM
$91.1B
$1.85M 0.48%
13,798
-28
-0.2% -$3.77K
ULTA icon
50
Ulta Beauty
ULTA
$22.7B
$1.8M 0.46%
+8,025
New +$1.73M

Similar funds

Foyston, Gordon, & Payne's Q3 2020 Portfolio in Review

As of Q3 2020, Foyston, Gordon, & Payne held 67 positions worth $388M, down 4.9% from $407M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $43M in Q3 2020, closing 3 positions and reducing 44 holdings. Its most notable exit was Oracle, an estimated $2.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Foyston, Gordon, & Payne opened a new position in CME Group worth $3.97M.

  • Foyston, Gordon, & Payne's largest Q3 2020 buy was CME Group: 23,717 shares worth $3.97M.
  • Foyston, Gordon, & Payne added most to Mondelez International in Q3 2020, an estimated $4.37M increase.
  • Foyston, Gordon, & Payne's biggest Q3 2020 reduction was Microsoft, cutting an estimated $8.11M.
  • Foyston, Gordon, & Payne fully exited Oracle in Q3 2020, selling an estimated $2.9M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 47% of its $388M portfolio in Q3 2020.
  • Foyston, Gordon, & Payne opened 4 new positions and closed 3 in Q3 2020.
  • Foyston, Gordon, & Payne's portfolio value fell 4.9% quarter-over-quarter to $388M.

Based on Foyston, Gordon, & Payne's 13F filing for Q3 2020, filed 12 Nov 2020.